Is vandetanib FDA approved?

AstraZeneca today announced that the US Food and Drug Administration (FDA) approved the orphan drug vandetanib for the treatment of medullary thyroid cancer that cannot be removed by surgery or that has spread to other parts of the body.

What is Caprelsa used for?

This medication is used to treat thyroid cancer (medullary type). It works by slowing or stopping the growth of cancer cells. Vandetanib belongs to a class of drugs known as tyrosine kinase inhibitors.

Who manufactures CAPRELSA?

Sanofi: Genzyme Strengthens Endocrinology Portfolio with Acquisition of Rare Disease Therapy Caprelsa® (vandetanib) from AstraZeneca.

Is caprelsa chemotherapy?

Caprelsa® Caprelsa® is the trade name for the generic chemotherapy drug Vandetanib. In some cases, health care professionals may use the generic name Vandetanib when referring to the trade name Caprelsa®.

Who makes vandetanib?

Vandetanib was approved by the FDA in April 2011, for treatment of late-stage thyroid cancer. Vandetanib was first initially marketed without a trade name; it has been marketed under the trade name Caprelsa since August 2011. In 2015 Genzyme acquired the product from AstraZeneca.

Is Avastin a chemo drug?

Avastin isn’t a chemotherapy drug.) But for some types of cancer, Avastin is approved for use on its own. Avastin contains the drug bevacizumab. It’s a monoclonal antibody, which is a type of drug that’s made from immune system cells.

What is vandetanib used for?

Vandetanib is used to treat a certain type of thyroid cancer that cannot be treated by surgery or that has spread to other parts of the body. Vandetanib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to multiply.

How do you pronounce vandetanib?

Pronunciation : van-DET-a-nib Latest prescription information about Vandetanib.